从豆类和伪谷物生产生物活性的最新方法
Manuel Martoccia1, Vincenzo Disca1, Yassine Jaouhari1
1Department of Pharmaceutical Sciences, Università degli Studi del Piemonte Orientale "Amedeo Avogadro", Largo Donegani 2, 28100 Novara, Italy.
Molecules (Basel, Switzerland)
|November 13, 2025
概括
豆类和伪谷物通过酶或发酵方法产生生物活性 (BAP). 这些可持续的植物蛋白提供健康益处,适合功能性食品.
科学领域:
- 食品科学与技术 食品科学与技术
- 生物技术是生物技术.
- 营养保健品 营养保健品
背景情况:
- 豆类和伪谷物是生物活性 (BAP) 的可持续来源.
- BAPs具有抗氧化,抗高血压,抗糖尿病,抗微生物和免疫调节的特性.
- 这些在植物性蛋白质中提供了重要的健康和可持续性潜力.
研究的目的:
- 审查从豆类和伪谷物生产BAP的生物基方法.
- 为了比较BAP生成的酶解水解和微生物发酵策略.
- 讨论BAP应用程序的计算工具和监管方面的整合.
主要方法:
- 用超声波或高压增强的酶化水解来控制BAP的释放.
- 微生物发酵用于复杂的混合物,改善感官质量,减少反营养素.
- In silico工具用于加速发现,目标相互作用预测和过程设计.
主要成果:
- 酶解水解提供受控的BAP释放,而发酵产生复杂的混合物,提高产品质量.
- 酶和发酵方法与计算工具的整合增强了BAP的生产和发现.
- 对欧盟,美国,日本和中国的监管框架进行了对BAP商业化进行审查.
结论:
- 生物基方法,特别是酶解水解和发酵,对于从豆类和伪谷物中生产BAP是有效的.
- 将这些方法与计算工具相结合,为释放植物蛋白的潜力提供了一个有希望的策略.
- 对功能性食品和营养保健品来说,解决工业扩展和应用方面的挑战至关重要.
相关概念视频
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Organic Acids
Lactic acid, an important organic acid extensively applied in food, pharmaceutical, and biodegradable polymer industries, is primarily produced via microbial fermentation. This method is favored over chemical synthesis due to its environmental sustainability and capacity for enantiomerically pure product formation. Among various microbial processes, the fermentation of starch-based substrates stands out due to the abundance and renewability of raw materials like corn and potatoes.Hydrolysis of...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Production of Biopesticides
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...
Bioplastics
Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...


